Although the TyG index has been widely recognized as a reliable marker of insulin resistance and a strong predictor of adverse health outcomes (12, 33), the CTI—a composite indicator integrating the TyG index with CRP, offers the advantage of capturing the synergistic effects of insulin resistance and systemic inflammation (34–36). This evidence concerns the gene CRP and Insulin resistance.